There are also clinical data suggesting that TP53 mutations may be permissive for ALT in human tumors; e.g., mutations in this gene are associated with ALT in human gliomas of the brain and spinal cord, a tumor type with high incidence of ALT phenotype [118]. Here, GPT is linked to central nervous system cancer.